Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8782319 | Journal of Pediatric and Adolescent Gynecology | 2017 | 13 Pages |
Abstract
NET-A in a dose greater than 10Â mg/d might be associated with increased risk for hepatic adenomas, likely due to peripheral conversion to ethinyl estradiol. Use of NET-A might not be advisable in patients with known hepatic adenomas.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paula C. MD, Stacey A. ScD, Marc R. MD,